NYSE:MMS - MAXIMUS Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$73.78 +1.86 (+2.59 %)
(As of 02/19/2019 08:47 AM ET)
Previous Close$71.92
Today's Range$72.18 - $73.81
52-Week Range$60.00 - $73.81
Volume509,044 shs
Average Volume367,370 shs
Market Capitalization$4.71 billion
P/E Ratio21.70
Dividend Yield1.39%
Beta1.02
MAXIMUS, Inc. provides business process services (BPS) to government health and human services programs worldwide. The company's Health Services segment offers various BPS, appeals, and assessments for state, provincial, and national government programs, including Medicaid, Children's Health Insurance Program, Affordable Care Act, Health Insurance British Columbia, Health Assessment Advisory Service contract, and Preadmission Screening and Resident Reviews. This segment offers program eligibility support and enrollment; application assistance and independent health plan enrollment counseling; beneficiary outreach, education, eligibility, enrollment, and renewal; document and record management; payment processing and administration; and digital eHealth and wellbeing solutions. It also provides independent disability, long-term sick, and other health assessment; occupational health clinical assessment; specialized consulting; and centralized multilingual customer contact centers and multichannel self-service options for enrollment. The company's U.S. Federal Services segment offers centralized citizen engagement centers and support services; document and record management; case management, citizen engagement, and consumer education; independent medical reviews and worker's compensation benefit appeals; and Medicare and Medicaid appeals, and program eligibility appeals. It also provides modernization of systems and information technology infrastructure; infrastructure operations and support services; software development, operations, and management services; and data analytics services. The company's Human Services segment offers national, state, provincial, and local human services agencies, as well as various BPS and related consulting services. It also provides management tools and professional consulting, program consulting, and tax credit and employer services. The company was founded in 1975 and is headquartered in Reston, Virginia.

Receive MMS News and Ratings via Email

Sign-up to receive the latest news and ratings for MMS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Business services, not elsewhere classified
Sub-IndustryData Processing & Outsourced Services
SectorBusiness Services
CUSIP57793310
Phone703-251-8500

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.39 billion
Cash Flow$4.6726 per share
Book Value$17.51 per share

Profitability

Net Income$220.75 million

Miscellaneous

Employees18,600
Market Cap$4.71 billion
OptionableOptionable

MAXIMUS (NYSE:MMS) Frequently Asked Questions

What is MAXIMUS's stock symbol?

MAXIMUS trades on the New York Stock Exchange (NYSE) under the ticker symbol "MMS."

How often does MAXIMUS pay dividends? What is the dividend yield for MAXIMUS?

MAXIMUS declared a quarterly dividend on Thursday, January 10th. Investors of record on Friday, February 15th will be given a dividend of $0.25 per share on Thursday, February 28th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 1.36%. The ex-dividend date is Thursday, February 14th. View MAXIMUS's Dividend History.

How will MAXIMUS's stock buyback program work?

MAXIMUS declared that its Board of Directors has approved a stock buyback program on Monday, June 25th 2018, which allows the company to buyback $200,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization allows the company to purchase up to 4.9% of its shares through open market purchases. Shares buyback programs are typically a sign that the company's board believes its stock is undervalued.

How were MAXIMUS's earnings last quarter?

MAXIMUS, Inc. (NYSE:MMS) issued its quarterly earnings results on Thursday, February, 7th. The health services provider reported $0.86 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.80 by $0.06. The health services provider earned $664.60 million during the quarter, compared to the consensus estimate of $672.08 million. MAXIMUS had a return on equity of 20.09% and a net margin of 8.94%. The firm's revenue for the quarter was up 6.7% on a year-over-year basis. During the same period last year, the company earned $0.89 EPS. View MAXIMUS's Earnings History.

When is MAXIMUS's next earnings date?

MAXIMUS is scheduled to release their next quarterly earnings announcement on Thursday, May 9th 2019. View Earnings Estimates for MAXIMUS.

What guidance has MAXIMUS issued on next quarter's earnings?

MAXIMUS issued an update on its FY19 earnings guidance on Thursday, February, 7th. The company provided EPS guidance of $3.55 to $3.75 for the period, compared to the Thomson Reuters consensus estimate of $3.63. The company issued revenue guidance of $2.93 billion to $3.00 billion, compared to the consensus revenue estimate of $2.95 billion.MAXIMUS also updated its FY 2019 guidance to $3.55-3.75 EPS.

What price target have analysts set for MMS?

1 analysts have issued 1-year target prices for MAXIMUS's shares. Their forecasts range from $67.00 to $81.00. On average, they anticipate MAXIMUS's share price to reach $74.00 in the next year. This suggests a possible upside of 0.3% from the stock's current price. View Analyst Price Targets for MAXIMUS.

What is the consensus analysts' recommendation for MAXIMUS?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MAXIMUS in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for MAXIMUS.

Has MAXIMUS been receiving favorable news coverage?

Media stories about MMS stock have trended positive this week, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. MAXIMUS earned a news impact score of 2.3 on InfoTrie's scale. They also assigned media coverage about the health services provider a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the company's share price in the near future.

Who are some of MAXIMUS's key competitors?

Who are MAXIMUS's key executives?

MAXIMUS's management team includes the folowing people:
  • Mr. Bruce L. Caswell, Pres, CEO & Director (Age 52)
  • Mr. Richard A. Montoni, Vice Chairman & Sr. Advisor to the CEO (Age 67)
  • Mr. Richard J. Nadeau, CFO & Treasurer (Age 64)
  • Mr. David R. Francis, Gen. Counsel & Sec. (Age 58)
  • Mr. Mark S. Andrekovich, Chief of Human Capital and Pres of Tax & Employer Services (Age 57)

Who are MAXIMUS's major shareholders?

MAXIMUS's stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (11.55%), Victory Capital Management Inc. (6.29%), Mackenzie Financial Corp (2.90%), Oregon Public Employees Retirement Fund (2.60%), Bank of New York Mellon Corp (1.86%) and Northern Trust Corp (1.73%). Company insiders that own MAXIMUS stock include Bruce Caswell, David Francis, Mark Andrekovich, Paul R Lederer, Raymond B Ruddy, Richard A Montoni and Russell A Beliveau. View Institutional Ownership Trends for MAXIMUS.

Which major investors are selling MAXIMUS stock?

MMS stock was sold by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC, First Quadrant L P CA, Brown Advisory Inc., D. E. Shaw & Co. Inc., Fort Washington Investment Advisors Inc. OH, Falcon Point Capital LLC, Handelsbanken Fonder AB and Mondrian Investment Partners LTD. Company insiders that have sold MAXIMUS company stock in the last year include David Francis, Mark Andrekovich, Paul R Lederer, Richard A Montoni and Russell A Beliveau. View Insider Buying and Selling for MAXIMUS.

Which major investors are buying MAXIMUS stock?

MMS stock was purchased by a variety of institutional investors in the last quarter, including Oregon Public Employees Retirement Fund, Mackenzie Financial Corp, Ranger Investment Management L.P., Geode Capital Management LLC, Acadian Asset Management LLC, BlackRock Inc., Epoch Investment Partners Inc. and Rhumbline Advisers. View Insider Buying and Selling for MAXIMUS.

How do I buy shares of MAXIMUS?

Shares of MMS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is MAXIMUS's stock price today?

One share of MMS stock can currently be purchased for approximately $73.78.

How big of a company is MAXIMUS?

MAXIMUS has a market capitalization of $4.71 billion and generates $2.39 billion in revenue each year. The health services provider earns $220.75 million in net income (profit) each year or $3.40 on an earnings per share basis. MAXIMUS employs 18,600 workers across the globe.

What is MAXIMUS's official website?

The official website for MAXIMUS is http://www.maximus.com.

How can I contact MAXIMUS?

MAXIMUS's mailing address is 1891 METRO CENTER DRIVE, RESTON VA, 20190. The health services provider can be reached via phone at 703-251-8500 or via email at [email protected]


MarketBeat Community Rating for MAXIMUS (NYSE MMS)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  362 (Vote Outperform)
Underperform Votes:  344 (Vote Underperform)
Total Votes:  706
MarketBeat's community ratings are surveys of what our community members think about MAXIMUS and other stocks. Vote "Outperform" if you believe MMS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MMS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/19/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel